<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Immune Mediated Inflammatory Disease

Rapidly select lead anti-inflammatory agents with our integrated preclinical platform

A Translational Platform of In Vivo Specialist Disease Models

Our catalogue of inflammation models recapitulates key clinical and pathological features of human disease, forming an integrated platform for preclinical drug development.

  • Model diverse autoimmune and inflammatory disease mechanisms in vivo.
  • Determine agent efficacy and response to treatment.
  • Rapidly select anti-inflammatory lead agents.

In most cases, we can initiate preclinical studies on our inflammation platform in as little as fourteen days. Promising agents can be quickly identified in vivo and advanced with confidence in their clinical efficacy.

Available Immune Mediated Inflammatory Disease Models

Systemic Lupus Erythematosus (SLE) In Vivo Models
Liver Injury In Vivo Models
Type 1 Diabetes (T1D) In Vivo Models
Hypersensitivity In Vivo Models
Multiple Sclerosis (MS)
In Vivo Models
Peritonitis In Vivo Models


Preclinical Immune Mediated Inflammatory Disease Platform Features

  • Comprehensive selection of acute and chronic inflammation models.
  • Diverse mechanisms of inflammatory and autoimmune disease.
  • Innate and regulatory cell-mediated models.
  • Robust determination of efficacy and response to treatment.
  • Expert model selection and study design consultation.



Discuss Your Inflammation Project

Tell us how we can help